Zheutlin AR, Derington CG, King JB, et al. - The probability of combination antihypertensive therapy was higher in relation to clinical and healthcare-access factors, including a healthcare visit within the previous year and co-morbid conditions.

• This cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES; 2013–2014 through 2017–2018) involved 1,597 participants (age ≥20 years) with hypertension and uncontrolled blood pressure (BP).

• Monotherapy prevalence, adjusted by age and gender, was 42.6% overall, 45.4% in non-Hispanic White, 31.9% in non-Hispanic Black, 39.6% in Hispanic, and 50.9% in non-Hispanic Asian adults.

• Overall, higher monotherapy use was reported in relation to higher systolic BP, while lower monotherapy use was observed in relation to older age, having a healthcare visit in the previous year, higher BMI, and having heart failure.